ZNF772 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.0244999998642E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.38889999956993E-07 |
Normal-vs-Stage2 |
1.85478999999988E-05 |
Normal-vs-Stage3 |
4.07560000004192E-06 |
Normal-vs-Stage4 |
7.62579999147306E-09 |
Stage1-vs-Stage2 |
6.327200E-01 |
Stage1-vs-Stage3 |
2.067600E-01 |
Stage1-vs-Stage4 |
1.770080E-04 |
Stage2-vs-Stage3 |
5.546200E-01 |
Stage2-vs-Stage4 |
5.302600E-03 |
Stage3-vs-Stage4 |
2.633700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.38610000033346E-07 |
Normal-vs-AfricanAmerican |
8.14880000000739E-05 |
Normal-vs-Asian |
2.040000E-03 |
Caucasian-vs-AfricanAmerican |
6.279400E-01 |
Caucasian-vs-Asian |
6.789200E-01 |
AfricanAmerican-vs-Asian |
5.411200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.20329999800484E-08 |
Normal-vs-Female |
2.643800E-03 |
Male-vs-Female |
3.499700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.23809999999802E-05 |
Normal-vs-Extreme_Weight |
8.26070000181645E-08 |
Normal-vs-Obese |
9.92560000000475E-05 |
Normal-vs-Extreme_Obese |
4.331700E-02 |
Normal_Weight-vs-Extreme_Weight |
4.905200E-01 |
Normal_Weight-vs-Obese |
7.996200E-01 |
Normal_Weight-vs-Extreme_Obese |
9.609400E-01 |
Extreme_Weight-vs-Obese |
2.863200E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.403400E-01 |
Obese-vs-Extreme_Obese |
8.423600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.877900E-02 |
Normal-vs-Age(41-60Yrs) |
1.74768999999797E-05 |
Normal-vs-Age(61-80Yrs) |
2.15769999978299E-07 |
Normal-vs-Age(81-100Yrs) |
1.70379999999692E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.924000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.186000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.639400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.113600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.207600E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.423800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.0583999999223E-07 |
Normal-VS-Type2 PRCC |
1.08120179476145E-11 |
Normal-VS-KIRP CIMP |
4.534300E-02 |
Normal-VS-Unclassified PRCC |
5.482800E-03 |
Type1 PRCC-VS-Type2 PRCC |
2.187200E-04 |
Type1 PRCC-VS-KIRP CIMP |
6.089400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
4.767600E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.667000E-01 |
Type2 PRCC-VS-Unclassified PRCC |
8.820000E-03 |
KIRP CIMP-VS-Unclassified PRCC |
3.747600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.58569865308323E-11 |
Normal-vs-N1 |
7.201100E-04 |
Normal-vs-N2 |
2.37879999999135E-05 |
N0-vs-N1 |
5.368000E-01 |
N0-vs-N2 |
6.078100E-02 |
N1-vs-N2 |
1.827820E-01 |
|
|